Indeed, in mouse MLL-AF9 model of AML, blocking of CCL3-CCR1/CCR5 and CXCL12-CXCR4 axes has reduced migration of Treg to the BM and has slowed down progression of leukemia [174]. This evidence concerns the gene KMT2A and acute myeloid leukemia.